Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.76 |
| ▸ | TSHR | P16473 | 2/20 | 0.76 |
| ▸ | TP53 | P04637 | 1/20 | 0.76 |
| ▸ | SLC6A4 | P31645 | 18/20 | 0.71 |
| ▸ | SLC6A3 | Q01959 | 17/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6419503 | 0.98 | CYP3A4 (0.78) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| Hydrochloric Acid SCHEMBL8008081 | 0.97 | CYP3A4 (0.76) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| SCHEMBL682189 | 0.88 | CYP3A4 (0.97) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| SCHEMBL2379467 | 0.88 | CYP3A4 (0.97) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| SCHEMBL2378403 | 0.88 | CYP3A4 (0.97) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| Hydrochloric Acid SCHEMBL2105 | 0.86 | CYP3A4 (1.00) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| Water SCHEMBL10423764 | 0.86 | CYP3A4 (0.94) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| Hydrochloric Acid SCHEMBL10336934 | 0.85 | CYP3A4 (0.97) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| SCHEMBL3517972 | 0.83 | SLC6A4 (1.00) | CYP3A4ALOX15TSHRTP53SLC6A4 | |
| Hydrochloric Acid SCHEMBL6476842 | 0.83 | SLC6A4 (0.71) | CYP3A4ALOX15TSHRTP53SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0230742-B1 | N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate and pharmaceutical compositions containing it | The Boots Company PLC (GB) | 1990-09-26 | — | — | EP | claimed |
| EP-1178789-B1 | METHOD OF TREATING EATING DISORDERS | ABBOTT GMBH & CO KG (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1169029-B1 | Use of sibutramine or its derivative for the treatment of sleep disorders | ABBOTT GMBH & CO KG (DE) | 2005-05-04 | — | — | EP | disclosed |
| EP-1169027-A4 | TREATMENT OF OSTEOARTHRITIS | ABBOTT GMBH & CO KG (DE) | 2004-10-20 | — | — | EP | disclosed |
| EP-1178789-A4 | METHOD OF TREATING EATING DISORDERS | ABBOTT GMBH & CO KG (DE) | 2004-02-18 | — | — | EP | disclosed |
| EP-1169029-A4 | METHOD OF TREATING SLEEP APNOEA | ABBOTT GMBH & CO KG (DE) | 2004-01-21 | — | — | EP | disclosed |
| EP-1169029-A4 | METHOD OF TREATING SLEEP APNOEA | ABBOTT GMBH & CO KG (DE) | 2004-01-21 | — | — | EP | disclosed |
| EP-1162966-A4 | WEIGHT LOSS AFTER PREGNANCY | KNOLL GMBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1162966-A4 | WEIGHT LOSS AFTER PREGNANCY | KNOLL GMBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1165060-A4 | TREATMENT OF GALLSTONES | KNOLL GMBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| WO-2000056318-A1 | TREATMENT OF NEUROPATHIC PAIN OR FIBROMYALGIA | KNOLL PHARMACEUTICAL COMPANY (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056321-A1 | TREATMENT OF HYPERACTIVITY DISORDERS | KNOLL PHARMACEUTICAL COMPANY (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056319-A1 | TREATMENT OF ORTHOSTATIC HYPOTENSION | KNOLL PHARMACEUTICAL COMPANY (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056317-A1 | WEIGHT LOSS AFTER PREGNANCY | KNOLL GMBH (DE) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056307-A1 | TREATMENT OF HIATIAL HERNIA | KNOLL GMBH (DE) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056313-A1 | METHOD OF CONTROLLING WEIGHT GAIN ASSOCIATED WITH THERAPEUTIC DRUGS | KNOLL GMBH (DE) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000054765-A1 | METHOD OF TREATING EATING DISORDERS | KNOLL GMBH (DE) | 2000-09-21 | — | — | WO | disclosed |
| EP-0814788-A4 | IMPROVING GLUCOSE TOLERANCE | BOOTS PHARMA INC (US) | 1999-05-06 | — | — | EP | disclosed |
| EP-0814788-A1 | IMPROVING GLUCOSE TOLERANCE | BOOTS PHARMACEUTICALS INC. (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0339280-A2 | Use of N,N-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine for treatment of cerebral disorders | The Boots Company PLC (GB) | 1989-11-02 | — | — | EP | disclosed |